AssayQuant Technologies, Inc.
PrivateLast Round
Grant
Aug 15, 2024
Total Funding Raised
$5.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AssayQuant Technologies, Inc. is a discovery tools company that develops and commercializes real-time, continuous enzyme activity assays, reagents, and services for drug discovery research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AssayQuant Technologies, Inc. Comparables
Compare AssayQuant Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BellBrook Labs | 84% | |
| SIRION Biotech | 77% | |
| BPS Bioscience | 76% | |
AssayQuant Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2024 | ||||
| VC Round | Mar 12, 2024 | ||||
| VC Round | Oct 1, 2023 | ||||
| Convertible Debt | Jul 12, 2023 | ||||
| Angel | May 14, 2021 |
Key People
Founding team and executive leadership
AssayQuant Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Future Labs Capital | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 94% MoM, from 4.2K to 8.2K.
- Dec 9, 2025
Added BIOMEDICA Medizinprodukte GmbH, a medical device distributor, as a customer.
AssayQuant Technologies, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |